Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Jirillo

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
La Radiologia Medica|November 1, 1989
[Peripheral lymphocyte populations in patients treated with pelvic and mediastinal radiotherapy]A Jirillo, M Balli, A Disperati, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Factors causing dose variability in drug administrationR Demicheli, A Jirillo, G Bonciarelli, et al.
Tumori|June 30, 1989
4'epidoxorubicin plus verapamil in anthracycline--refractory cancer patientsR Demicheli, A Jirillo, G Bonciarelli, et al.
Oncology|May 2, 2009
Circulating and disseminated tumor cells in the clinical management of breast cancer patients: unanswered questionsA Amadori, E Rossi, R Zamarchi, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Neurotoxicity after chemotherapy with vinorelbineF Lonardi, G Pavanato, V Ferrari, et al.
Haematologica|March 1, 1994
Primary lymphoma of the vagina. A case reportF Lonardi, V Ferrari, G Pavanato, et al.
Minerva Medica|January 28, 1982
[Approach to the problem of economic costs of the medical therapy of tumors]G F Garusi, R Demicheli, A Jirillo, et al.
Tumori|February 28, 1985
Pharmacologic data and technical feasibility of intraperitoneal doxorubicin administrationR Demicheli, G Bonciarelli, A Jirillo, et al.
Tumori|October 31, 1987
Pilot study of intravenous administration of the acid-treated Salmonella minnesota R595 (Re) in cancer patientsA Jirillo, A Disperati, M Balli, et al.
Tumori|October 31, 1982
Pharmacological data and technical feasibility of intraperitoneal 5-fluorouracil administrationR Demicheli, A Jirillo, G Bonciarelli, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
La Radiologia Medica|November 1, 1989
[Peripheral lymphocyte populations in patients treated with pelvic and mediastinal radiotherapy]A Jirillo, M Balli, A Disperati, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Factors causing dose variability in drug administrationR Demicheli, A Jirillo, G Bonciarelli, et al.
Tumori|June 30, 1989
4'epidoxorubicin plus verapamil in anthracycline--refractory cancer patientsR Demicheli, A Jirillo, G Bonciarelli, et al.
Oncology|May 2, 2009
Circulating and disseminated tumor cells in the clinical management of breast cancer patients: unanswered questionsA Amadori, E Rossi, R Zamarchi, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Neurotoxicity after chemotherapy with vinorelbineF Lonardi, G Pavanato, V Ferrari, et al.
Haematologica|March 1, 1994
Primary lymphoma of the vagina. A case reportF Lonardi, V Ferrari, G Pavanato, et al.
Minerva Medica|January 28, 1982
[Approach to the problem of economic costs of the medical therapy of tumors]G F Garusi, R Demicheli, A Jirillo, et al.
Tumori|February 28, 1985
Pharmacologic data and technical feasibility of intraperitoneal doxorubicin administrationR Demicheli, G Bonciarelli, A Jirillo, et al.
Tumori|October 31, 1987
Pilot study of intravenous administration of the acid-treated Salmonella minnesota R595 (Re) in cancer patientsA Jirillo, A Disperati, M Balli, et al.
Tumori|October 31, 1982
Pharmacological data and technical feasibility of intraperitoneal 5-fluorouracil administrationR Demicheli, A Jirillo, G Bonciarelli, et al.
Pageof 4